RENODAPT S 180MG TABLET
₹576.9*
MRP ₹641
10% off
₹545*
MRP ₹641
15% CB
₹96 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
RENODAPT S 180MG TABLET belongs to a class of medications called ‘immunosuppressants’ used to prevent the body from rejecting a transplanted organ such as a kidney, heart or liver. Transplant rejection occurs when the recipient’s immune system identifies the transplanted organ as a ‘foreign object’ and attacks it. If it is not treated promptly, it may cause irreversible damage.
RENODAPT S 180MG TABLET contains ‘Mycophenolate sodium’ used in the treatment of organ transplant rejection along with another immunosuppressant and anti-inflammatory agent. It inhibits T and B lymphocytes (white blood cells that attack foreign cells) and suppresses antibodies' production (identify and kill foreign cells). These effects suppress the immune system so that the transplanted graft is not rejected.
You are advised to take RENODAPT S 180MG TABLET for as long as your doctor has prescribed it for you depending on your medical condition. In some cases, you may experience certain common side-effects, such as diarrhoea, cough, muscle pain, low blood pressure, fever and respiratory infections. Most of these side-effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side-effects persistently.
To treat your condition effectually, continue taking RENODAPT S 180MG TABLET for as long as your doctor has prescribed. To avoid recurring symptoms, do not stop it midway. Do not take RENODAPT S 180MG TABLET if you are pregnant or planning for pregnancy. RENODAPT S 180MG TABLET should not be taken by breastfeeding mothers as it passes into breast milk. RENODAPT S 180MG TABLET should not be given to children as safety and efficacy have not been established. RENODAPT S 180MG TABLET may make you more susceptible to infections, consult your doctor if you develop fever, sore throat, breathlessness, jaundice, unexplained bleeding or bruising. Avoid excessive exposure to sunlight, wear protective clothing, and use protective sunscreen with a high protection factor while using RENODAPT S 180MG TABLET. Do not contact anyone who has shingles, chickenpox, or measles. Do not take RENODAPT S 180MG TABLET if you are not using effective contraception.
RENODAPT S 180MG TABLET contains ‘Mycophenolate sodium’ which belongs to the class of ‘immunosuppressants’. It is used to prevent organ transplant rejection. It reduces the activity of the immune system by inhibiting the action of white blood cells (responsible for immune reactions) in the body.
Do not take RENODAPT S 180MG TABLET if you are allergic to any immunosuppressant medicines or mycophenolate sodium. Let your doctor know before using RENODAPT S 180MG TABLET if you have liver or kidney problems, severe digestive issues, cancer, liver disease (such as hepatitis B, hepatitis C), current/past infections, rare genetic disorders (such as Lesch-Nyhan or Kelley-Seegmiller syndromes). Do not take RENODAPT S 180MG TABLET if you are pregnant or planning for pregnancy as RENODAPT S 180MG TABLET is a Pregnancy category risk D medicine which can cause serious congenital disabilities to the unborn baby. RENODAPT S 180MG TABLET should not be taken by breastfeeding mothers as it passes into breast milk. Pregnant women should use reliable forms of birth control while on treatment and for six weeks after stopping treatment with RENODAPT S 180MG TABLET. While taking RENODAPT S 180MG TABLET, do not contact anyone who has shingles, chickenpox, or measles. RENODAPT S 180MG TABLET causes dizziness and drowsiness, so drive with caution. RENODAPT S 180MG TABLET should not be given to children as safety and efficacy have not been established. Avoid consuming alcohol along with RENODAPT S 180MG TABLET as it could lead to increased dizziness. Your doctor may advise you to undergo regular blood tests, kidney and liver tests to monitor your condition. Avoid excessive exposure to sunlight, wear protective clothing, and use protective sunscreen with a high protection factor while using RENODAPT S 180MG TABLET.
Drug-Drug Interactions: RENODAPT S 180MG TABLET may have interaction with other immunosuppressant medicines (tacrolimus), medicines used to treat high blood cholesterol levels (cholestyramine), activated charcoal used to treat digestive problems, antacids containing magnesium and aluminium and medicines used to treat viral infections (aciclovir or ganciclovir).
Drug-Food Interactions: Avoid alcohol consumption while taking RENODAPT S 180MG TABLET as it may increase dizziness.
Drug-Disease Interactions: RENODAPT S 180MG TABLET may cause interactions with disease conditions such as cancer, liver disease (such as hepatitis B, hepatitis C), current/past infections, serious digestive problems, rare genetic disorders (such as Lesch-Nyhan or Kelley-Seegmiller syndromes).
Organ transplant rejection: When you get a new organ transplanted into your body, your body recognizes it as a foreign element and tries to attack and reject it because it is not originally part of your body. So, immunosuppressant drugs are given to such patients to suppress the immune system, stopping it from attacking the newly transplanted organs. Warnings signs of rejection are flu-like symptoms such as chills, headache, nausea, or vomiting, fever higher than 100o F, newly found pain at the region of the transplanted organ, weight gain and fatigue.
Country of origin
Manufacturer/Marketer address
Alcohol
Unsafe
You are recommended to avoid alcohol consumption while taking RENODAPT S 180MG TABLET. It could lead to increased dizziness and drowsiness.
Pregnancy
Unsafe
RENODAPT S 180MG TABLET may cause birth defects and miscarriage if taken during pregnancy. Follow contraception advice given by your doctor if you are a woman who could become pregnant. Also, undergo a pregnancy test before starting treatment with RENODAPT S 180MG TABLET.
Breast Feeding
Unsafe
It is not recommended to take RENODAPT S 180MG TABLET while you are breastfeeding. RENODAPT S 180MG TABLET passes into breast milk.
Driving
Caution
RENODAPT S 180MG TABLET may cause dizziness, tiredness, do not drive or operate heavy machinery if you feel dizzy.
Liver
Caution
Take RENODAPT S 180MG TABLET only after the doctor's prescription, especially if you have liver diseases/conditions as your doctor may adjust the dose as required.
Kidney
Caution
Please consult your doctor if you have kidney impairment before taking RENODAPT S 180MG TABLET as your doctor may adjust the dose as required.
Children
Unsafe
RENODAPT S 180MG TABLET should not be used by children below 18 years of age, as the efficacy and safety have not been established.
Product Substitutes